Explore real-world examples of how Grace Fine Chemical Manufacturing Services (FCMS) delivers innovative solutions for API development and scale-up. Download the full case studies to learn how we work closely with pharmaceutical companies to overcome critical challenges in yield, purity, and stability.
A West Coast biotech faced unacceptable impurity levels and inconsistent yields during early-phase API development. Discover how we helped streamline production, reduce reaction time by 50%, and minimize impurities.
Critical Outcome: Consistent yields and purity, enabling timely drug development.
A small biotech struggled with an inefficient purification process that was causing a bottleneck in the API manufacturing process. Using our deep analytical and synthetic chemistry expertise, we were able to uncover the root causes of impurity formation and boost yield from 51% to 87%.
Critical Outcome: 70% yield improvement, reduced manufacturing costs, and maintained clinical development timelines.
An emerging biotech needed a toxicology lot for their preclinical project but faced disappointingly low product yield. We employed multiple analytical techniques to reveal critical insights that enabled us to mitigate product decomposition and significantly increase yield.
Critical Outcome: >25% yield increase and rapid solution implementation.